Venture-backed Chinese drugmaker Hinova raises $167m in STAR Market IPO

Venture-backed Chinese drugmaker Hinova raises $167m in STAR Market IPO

Source: Laurynas Mereckas/Unsplash

13 April, 2022

fosun pharma Hinova Pharmaceuticals STAR Market

Printed by Unregistered user on Tue, 16 Dec 2025 04:19:57 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China-US drugmaker JOINN Biologics raises $150m in Series B led by CPE

Chinese insurers lead $150m rounds in biotech startup METiS

Read more from Greater China

Chinese AI chip firm Biren eyes Hong Kong IPO in coming weeks

Policy & Regulations

Beijing bourse weighs overhaul of IPO subscription rules as idle capital surges